ClinicalTrials.govpublic full text
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
castrate resistant prostate cancer, nut carcinoma, chronic myelomonocytic leukemia, myelofibrosis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869807
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.